These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 13468429)

  • 1. [Treatment with peroral antidiabetic drug invenol (BZ-55) and rastinon (D-860) of tuberculotic diabetics].
    KONIGSTEIN RP; SUESS H
    Wien Klin Wochenschr; 1957 Jul; 69(28):501-5. PubMed ID: 13468429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of tuberculous diabetics with the new peroral antidiabetic agents].
    TICHOLOV K; DOBREV P
    Munch Med Wochenschr; 1959 Feb; 101(7):286-9. PubMed ID: 13644087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dispensary treatment of tuberculotic diabetics].
    UNGR J
    Cesk Zdrav; 1958 Mar; 6(3):133-4. PubMed ID: 13537135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differences between rastinon and invenol in ambulant treatment of diabetes mellitus].
    ILLIG H
    Munch Med Wochenschr; 1958 Jan; 100(3):117-9. PubMed ID: 13517147
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of tuberculous diabetics with new peroral antidiabetic drugs].
    TIKHOLOV K; DOBREV PS
    Suvr Med (Sofiia); 1959; 10(12)():39-52. PubMed ID: 13838376
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of associated diabetes & tuberculosis with peroral antidiabetics].
    REALE M; ANSELMO B; BASSO L; SICCARDI L
    Gazz Med Ital; 1959 Feb; 118(2):51-8. PubMed ID: 13653340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of sulfonyl ureas in diabetics with tuberculosis].
    DADDI G; GRASSI C
    G Ital Della Tuberc; 1957; 11(4):211-7. PubMed ID: 13474409
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral treatment of diabetes mellitus with rastinon (D-860)].
    MOHNIKE G
    Rev Iber Endocrinol; 1957; 4(21):295-307. PubMed ID: 13466478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rastinon, a peroral diabetic without antibacterial effect].
    BLOCH J; LENHARDT A
    Wien Med Wochenschr; 1957 Nov; 107(45):917-9. PubMed ID: 13531041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes mellitus with oraily administered hypoglycemic agents; BZ-55 or carbutamide and D-860 or tolbutamide].
    JOSELEVICH M; CALVAGNO M; KABANCHIK M
    Prensa Med Argent; 1958 Jan; 45(3):315-8. PubMed ID: 13567427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug interactions of selected drugs used by patients with diabetes mellitus].
    Prokes M; Suchopár J
    Vnitr Lek; 2009 Apr; 55(4):395-402. PubMed ID: 19449757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoglycemic sulfamides as treatment of diabetic tuberculous patients].
    LOUSTAU-CHARTEZ M; VASSEUR B
    Presse Med (1893); 1958 Jun; 66(45):1022-3. PubMed ID: 13567507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of D 860 (butyltolylsulfonylcarbamide) & BZ 55 (butylsulfonylcarbamide) in the treatment of diabetes].
    JUTORAN M
    Prensa Med Argent; 1957 Mar; 44(13):985-7. PubMed ID: 13477712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on diabetics with P 607 (chlorpropamide), a new peroral antidiabetic].
    HEINSEN HA; GEHN G; HAGEN H
    Med Klin; 1958 Sep; 53(39):1685-8. PubMed ID: 13589593
    [No Abstract]   [Full Text] [Related]  

  • 16. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tests of BZ 55 and D 860 tablets in oral therapy of diabetes mellitus].
    BRAGA M; RODRIGUES DM; DOS SANTOS DM
    Med Contemp; 1958 Apr; 76(4):173-91. PubMed ID: 13551547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of body weight during antidiabetic treatment].
    Hamann A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolbutamide (artosin, rastinon, D 860) in diabetes; clinical trials continued.
    JACKSON WP
    S Afr Med J; 1958 Feb; 32(6):153-8. PubMed ID: 13529208
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.